BACKGROUND: Helicobacter pylori infection induces a biased T helper type 1 (Th1) response that produces IFN-gamma and Fas ligand (FasL). Th1 cytokines are associated with apoptosis in the gastric epithelial cells. AIM: We aimed to define the role of the recently cloned IL-18, a IFN-gamma inducing factor, in gastric mucosal injury induced by H. pylori infection. METHODS: Twenty-seven gastric ulcer (GU) patients and 20 functional dyspepsia (FD) patients were enrolled in this study. Mucosal biopsy samples were obtained from the gastric antrum and GU site during endoscopy. Samples were used for histological examination, H. pylori culture and in-situ stimulation for 48 h in the presence of 10 microg/ml phytohemagglutinin-P. IL-18, IFN-gamma, and soluble FasL (sFasL) levels in culture supernatants were assayed by the enzyme-linked immunosorbent assay method. IL-18, IL-1beta-converting enzyme (ICE) and caspase-3 were evaluated by western blotting in gastric cancer cell lines (MKN45) cocultured with H. pylori. RESULTS: All 27 GU patients and ten out of 20 FD patients were found to be H. pylori-positive, whereas ten FD patients were H. pylori-negative. Antral mucosal tissues from H. pylori-positive FD patients contained (P<0.01) higher levels of IL-18, IFN-gamma, and sFasL than those from uninfected FD patients. IL-18, IFN-gamma, and sFasL levels at the ulcer site were significantly (P<0.01) higher than those at distant sites in the antrum. A significant relationship was seen between IL-18 and IFN-gamma levels at the ulcer site (r=0.7, P<0.01). H. pylori eradication led to a significant decrease in the levels of IL-18, IFN-gamma, and sFasL at the ulcer site. Western blotting showed that IL-18, ICE, and caspase-3 were activated in gastric cancer cell lines cocultured with H. pylori. CONCLUSION: This study suggests that H. pylori infection enhanced mucosal injury by stimulating a Th1 response, which was mediated by IL-18 upregulation as well as activation of ICE and caspase-3.
BACKGROUND:Helicobacter pyloriinfection induces a biased T helper type 1 (Th1) response that produces IFN-gamma and Fas ligand (FasL). Th1 cytokines are associated with apoptosis in the gastric epithelial cells. AIM: We aimed to define the role of the recently cloned IL-18, a IFN-gamma inducing factor, in gastric mucosal injury induced by H. pylori infection. METHODS: Twenty-seven gastric ulcer (GU) patients and 20 functional dyspepsia (FD) patients were enrolled in this study. Mucosal biopsy samples were obtained from the gastric antrum and GU site during endoscopy. Samples were used for histological examination, H. pylori culture and in-situ stimulation for 48 h in the presence of 10 microg/ml phytohemagglutinin-P. IL-18, IFN-gamma, and soluble FasL (sFasL) levels in culture supernatants were assayed by the enzyme-linked immunosorbent assay method. IL-18, IL-1beta-converting enzyme (ICE) and caspase-3 were evaluated by western blotting in gastric cancer cell lines (MKN45) cocultured with H. pylori. RESULTS: All 27 GU patients and ten out of 20 FDpatients were found to be H. pylori-positive, whereas ten FDpatients were H. pylori-negative. Antral mucosal tissues from H. pylori-positive FDpatients contained (P<0.01) higher levels of IL-18, IFN-gamma, and sFasL than those from uninfected FDpatients. IL-18, IFN-gamma, and sFasL levels at the ulcer site were significantly (P<0.01) higher than those at distant sites in the antrum. A significant relationship was seen between IL-18 and IFN-gamma levels at the ulcer site (r=0.7, P<0.01). H. pylori eradication led to a significant decrease in the levels of IL-18, IFN-gamma, and sFasL at the ulcer site. Western blotting showed that IL-18, ICE, and caspase-3 were activated in gastric cancer cell lines cocultured with H. pylori. CONCLUSION: This study suggests that H. pylori infection enhanced mucosal injury by stimulating a Th1 response, which was mediated by IL-18 upregulation as well as activation of ICE and caspase-3.
Authors: T Shimizu; K Kusugami; K Ina; A Imada; Y Nishio; T Hosokawa; M Ohsuga; M Shimada; M Noshiro; H Kaneko; T Ando Journal: Digestion Date: 2000 Impact factor: 3.216
Authors: S Fiorucci; L Santucci; E Antonelli; E Distrutti; G Del Sero; O Morelli; L Romani; B Federici; P Del Soldato; A Morelli Journal: Gastroenterology Date: 2000-02 Impact factor: 22.682
Authors: T Tomita; A M Jackson; N Hida; M Hayat; M F Dixon; T Shimoyama; A T Axon; P A Robinson; J E Crabtree Journal: J Infect Dis Date: 2001-01-24 Impact factor: 5.226
Authors: M Shimada; K Ina; K Kyokane; A Imada; H Yamaguchi; Y Nishio; M Hayakawa; Y Iinuma; M Ohta; T Ando; K Kusugami Journal: Scand J Gastroenterol Date: 2002-05 Impact factor: 2.423
Authors: Taslima T Lina; Irina V Pinchuk; Jennifer House; Yoshio Yamaoka; David Y Graham; Ellen J Beswick; Victor E Reyes Journal: J Immunol Date: 2013-08-30 Impact factor: 5.422
Authors: Camila A Figueiredo; Cintia Rodrigues Marques; Ryan dos Santos Costa; Hugo Bernardino F da Silva; Neuza M Alcantara-Neves Journal: World J Gastroenterol Date: 2014-05-14 Impact factor: 5.742